Unknown

Dataset Information

Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer.


ABSTRACT:

SUBMITTER: Pocha PV 

PROVIDER: S-EPMC7859795 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature